Synthetic RNA-based post-transcriptional expression control methods and genetic circuits
Authors:
- 11 March 2022
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 184, 114196
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 127 references indexed in Scilit:
- Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct MechanismsCell, 2011
- Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNACell Stem Cell, 2010
- Rationally designed logic integration of regulatory signals in mammalian cellsNature Nanotechnology, 2010
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based MechanismsMolecular Therapy, 2010
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological StabilityMolecular Therapy, 2008
- A modular and extensible RNA-based gene-regulatory platform for engineering cellular functionProceedings of the National Academy of Sciences, 2007
- Tetracycline aptamer-controlled regulation of pre-mRNA splicing in yeastNucleic Acids Research, 2007
- Different modes and potencies of translational repression by sequence-specific RNA–protein interaction at the 5′-UTRNucleic Acids Research, 2006
- Engineering RNA sequence specificity of Pumilio repeatsProceedings of the National Academy of Sciences, 2006